Militello John — SEC Form 4 filings
SEC reporting owner CIK 1662170. 29 Form 4 filings on record with FilingPulse; latest filed 2026-05-28.
Transaction summary — filings shown
Covers all 29 filings on record, filed 2024-01-22 to 2026-05-28. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 27 legs across 23 filings — 71,887 shares, $808,970 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 39.
- Largest priced transaction: sale of 10,000 shares @ $29.84 ($298,450) in ROCKET PHARMACEUTICALS, INC., filed 2024-03-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | See Remarks | 29 | — | 27 legs · 71,887 sh · $808,970 | 39 |
Form 4 filings — Militello John
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-28 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 2,000 (derivative) · +11 more | EDGAR |
| 2026-05-21 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 384 @ $3.01 | EDGAR |
| 2026-05-14 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 855 @ $3.61 | EDGAR |
| 2026-02-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 1,157 @ $3.34 | EDGAR |
| 2026-02-18 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 3,726 @ $3.31 | EDGAR |
| 2026-02-13 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 29,982 @ $0 · Grant/award (A): 45,018 (derivative) @ $0 | EDGAR |
| 2025-11-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 1,086 @ $2.98 | EDGAR |
| 2025-10-16 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 19,841 @ $3.96 · Sale (S): 5,514 @ $3.96 · Sale (S): 3,005 @ $3.97 · Sale (S): 558 @ $3.98 | EDGAR |
| 2025-09-09 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-08-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 699 @ $3.06 · Sale (S): 361 @ $3.00 | EDGAR |
| 2025-08-18 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 7,043 @ $3.02 | EDGAR |
| 2025-05-22 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 357 @ $6.45 | EDGAR |
| 2025-05-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 655 @ $6.53 | EDGAR |
| 2025-04-24 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 718 @ $7.16 | EDGAR |
| 2025-02-25 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 2,737 @ $10.58 | EDGAR |
| 2025-02-13 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/award (A): 20,080 @ $0 · Grant/award (A): 29,920 (derivative) @ $0 | EDGAR |
| 2025-01-27 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 896 @ $10.38 | EDGAR |
| 2024-11-25 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 1,224 @ $13.05 | EDGAR |
| 2024-11-04 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 917 @ $16.62 | EDGAR |
| 2024-08-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 1,064 @ $18.50 | EDGAR |
| 2024-07-24 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 812 @ $23.02 | EDGAR |
| 2024-05-20 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 1,079 @ $23.35 | EDGAR |
| 2024-04-24 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 833 @ $22.87 | EDGAR |
| 2024-03-25 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Other (J): 2,903 @ $0 · Other (J): 7,932 @ $0 · Other (J): 14,310 @ $0 · Other (J): 11,067 @ $0 · Sale (S): 2,490 @ $28.10 · Other (J): 2,903 (derivative) @ $0 · +3 more | EDGAR |
| 2024-03-04 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Option exercise (M): 10,000 @ $12.55 · Sale (S): 10,000 @ $29.84 · Option exercise (M): 10,000 (derivative) @ $12.55 | EDGAR |
| 2024-02-21 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 3,238 @ $29.84 · Grant/award (A): 8,322 @ $0 · Grant/award (A): 24,545 (derivative) @ $0 | EDGAR |
| 2024-02-16 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Option exercise (M): 6,274 @ $0 · Option exercise (M): 725 (derivative) @ $0 · Option exercise (M): 5,549 (derivative) @ $0 | EDGAR |
| 2024-01-23 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale (S): 638 @ $27.20 | EDGAR |
| 2024-01-22 | 4 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Option exercise (M): 1,586 @ $0 · Option exercise (M): 1,586 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662170 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →